The Human Variable 

Infection-associated chronic conditions (IACCs), including Long COVID, ME/CFS, post-treatment Lyme disease syndrome (PTLDS), and related post-infectious syndromes, present a persistent challenge to conventional medical workflows. These conditions are multi-system, fluctuating, and temporally delayed, with symptom expression shaped by environmental exposures, autonomic regulation, immune reactivity, hormonal state, and cumulative demand.

Climate change is accelerating fungal evolution at the same moment millions of Americans are living with post-COVID immune instability. This white paper introduces CYNAERA’s national fungal-intelligence architecture, integrating climate analytics, immune-terrain modeling, wastewater genomics, micro-clinic stabilization, and antifungal combination logic. It explains why fungal threats are rising, how existing federal infrastructure can be repurposed immediately and what the Un

The Physics of Survival reframes human stability as the core infrastructure of civilization. This white paper introduces Terrain Intelligence—a unifying systems framework that links space medicine, chronic illness, and climate resilience under one predictive model. Drawing on NASA Human Research Program findings and longitudinal public-health data, Cynthia Adinig demonstrates that physiological collapse in microgravity mirrors the same autonomic and immune failure seen in Lon

Growth used to mean speed. But speed without structure only burns out people and potential. Real growth requires alignment of mission, technology, and trust. At CYNAERA, collaboration is not a slogan. It is the architecture that holds every system together.

FEMA’s flood plans overlook infection-associated chronic conditions now affecting one-quarter of U.S. adults. This CYNAERA white paper introduces biologic disaster modeling using US-CCUC™, ESA™, VitalGuard™, and MoldX™ to forecast medical surges from mold, heat, and power loss. Applying these systems could prevent 70 percent of non-trauma ER visits and save $7.4 billion annually in federal costs.

This future ready framework was built from real world data, patient-led insights and cutting-edge biomarker science. 35–50 million Americans. 25–30% global prevalence. $1 trillion annual impact. The world can’t afford diagnostics that guess, it needs diagnostics that know. Read the groundbreaking Composite Diagnostic Fingerprint for Long COVID, authored by patient-turned-subject matter expert Cynthia Adinig. Nobel Prize worthy thinking. Welcome to CYNAERA. Where technology m